Mode
Text Size
Log in / Sign up

Real-World Registry Evaluates Perceval Bioprosthesis Via Mini-Thoracotomy Versus Mini-Sternotomy in Aortic Valve Replacement PatientsMini-Aortic Surgery Saves Time Without Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note registry findings of shorter hospital stays with mini-thoracotomy but no long-term difference versus mini-sternotomy for AVR.

This prospective international real-world registry study evaluated surgical approaches for aortic valve replacement across 55 institutions. The population consisted of patients undergoing isolated aortic valve replacement by minimally invasive cardiac surgery approaches. A total of 1,652 patients were enrolled in the registry. Following propensity score matching, the analysis included 261 patients per approach to compare the two surgical techniques.

The intervention involved implanting the Perceval sutureless bioprosthesis via mini-thoracotomy, while the comparator utilized the same bioprosthesis via mini-sternotomy. Results indicated that intensive care unit stay and hospital stay were shorter in the mini-thoracotomy group compared to the mini-sternotomy group. However, the specific p-values for these differences were truncated in the source data, preventing precise statistical assessment. Perioperative complication rates were reported as low for both groups.

Long-term clinical and echocardiographic outcomes demonstrated no significant differences between the mini-thoracotomy and mini-sternotomy approaches. Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in the registry. The study design is observational, which limits the ability to establish causality between the surgical approach and outcomes. Follow-up duration was not reported, and key limitations were not detailed in the source material. Clinicians should interpret these findings cautiously given the registry nature and missing safety details.

Imagine walking into the hospital for heart surgery and leaving two days sooner. That is the promise of a new way to replace a faulty heart valve.

Millions of people suffer from stiff or leaking aortic valves. These valves act like doors that control blood flow to the rest of the body. When they fail, the heart has to work much harder.

Doctors usually open the chest fully to fix these valves. This is safe but takes a long time to recover from. Many patients face weeks of pain and limited movement.

The Surprising Shift

For years, surgeons had to choose between a large cut or a smaller one. The smaller cut often meant higher risks or more complications.

But here is the twist. A new device called the Perceval sutureless bioprosthesis changes the game. It snaps into place without the need for heavy stitching.

What Scientists Didn't Expect

The real surprise came from comparing two small incisions. One is a mini-sternotomy, which cuts through the breastbone. The other is a mini-thoracotomy, which cuts between the ribs.

Doctors thought the rib cut might be harder on the patient. They worried it would cause more pain or take longer to heal.

Think of the heart valve like a door that won't close properly. Old methods required a team of people to sew a new door in place. This took hours and caused a lot of swelling.

The Perceval device is different. It is designed to lock into the heart wall on its own. It is like a specialized key that fits perfectly into a lock without needing extra tools.

Because it does not need heavy stitching, the body reacts less to the surgery. This means less inflammation and faster healing.

Researchers looked at data from 1,652 patients across 55 different hospitals. They tracked everyone from 2011 to 2021.

They focused on the 710 patients who had the new valve through a small cut. To make the results fair, they matched patients carefully. This ensured both groups were similar in age and health before the surgery.

The main result was clear and encouraging. Patients who got the valve through the rib cut stayed in the hospital for fewer days. They also spent less time in the intensive care unit.

The study showed very low rates of complications. This means fewer infections, bleeding issues, or other problems during recovery.

But there is a catch.

While the recovery time was better, the long-term results were the same for both groups. The new valve worked just as well as the other method over time.

This fits into a bigger picture of less invasive heart surgery. The goal is to give patients the best valve with the least amount of trauma to their body.

Using a device that needs less sewing helps surgeons operate faster. It also reduces the stress on the patient's chest wall. This is especially helpful for older adults who cannot handle long surgeries.

This information is important if you or a loved one needs heart valve surgery. It shows that a smaller cut between the ribs is a safe option.

You can ask your doctor if this specific device is available at your hospital. If it is, you might be able to go home sooner.

It is important to remember this is still research. The study looked at specific types of patients. Not everyone is a candidate for this smaller cut.

Also, the study was international, which is good, but every hospital is different. Your doctor knows your specific health history best.

More hospitals are likely to adopt this technique as they see the results. Researchers will continue to study long-term data to ensure safety.

This research gives hope for faster recovery. It means patients can return to their normal lives sooner. The future of heart surgery is getting smaller and smarter.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
The aim of this study was to report clinical and hemodynamic results from a real-world registry of aortic valve replacement (AVR) with the Perceval sutureless bioprosthesis, comparing mini-sternotomy (MS) versus mini-thoracotomy (MT) approach. This prospective international registry enrolled 1,652 patients across 55 institutions between 2011 and 2021. Patients undergoing isolated AVR by minimally invasive cardiac surgery approaches were analyzed. Preoperative covariates were adjusted using 1:1 propensity score matching, reaching a final cohort of 261 patients for each approach. Isolated AVR via minimally invasive approaches was performed in 710 patients—406 in MS and 304 in MT. After matching, the baseline characteristics were similar between the two groups, except for the preoperative NYHA class distribution. MT was associated with shorter intensive care unit and hospital stays (p =  Our propensity-matched analysis demonstrates that the use of Perceval in minimally invasive approaches is associated with low perioperative complication rates. Sutureless implanted in MT has lower intensive care and in-hospital stay without significant differences in long-term clinical and echocardiographic outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.